Home Cart Sign in  
Chemical Structure| 1952236-05-3 Chemical Structure| 1952236-05-3

Structure of MTX-211
CAS No.: 1952236-05-3

Chemical Structure| 1952236-05-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MTX-211 is a dual inhibitor of EGFR and PI3K, used for the treatment of cancer and other diseases.

Synonyms: Mol 211

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MTX-211

CAS No. :1952236-05-3
Formula : C20H14Cl2FN5O2S
M.W : 478.33
SMILES Code : CS(=O)(=O)NC1=CC(=CN=C1Cl)C1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1
Synonyms :
Mol 211
MDL No. :MFCD31620832
InChI Key :GUYKCXXNIKKSBC-UHFFFAOYSA-N
Pubchem ID :121416213

Safety of MTX-211

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of MTX-211

RTK
PI3K-AKT
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • PI3K

  • EGFR/ErbB1

In Vitro:

Cell Line
Concentration Treated Time Description References
HUVEC cells 0, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM 48 and 72 hours The sensitivity of normal epithelial cells was less than that of the cancer cell lines Int J Mol Sci. 2023 Apr 20;24(8):7608
SV-HUC-1 cells 0, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM 48 and 72 hours The sensitivity of normal epithelial cells was less than that of the cancer cell lines Int J Mol Sci. 2023 Apr 20;24(8):7608
UMUC3 cells 0, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM 48 and 72 hours MTX-211 significantly decreased cancer cell viability in a time- and concentration-dependent manner Int J Mol Sci. 2023 Apr 20;24(8):7608
EJ cells 0, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM 48 and 72 hours MTX-211 significantly decreased cancer cell viability in a time- and concentration-dependent manner Int J Mol Sci. 2023 Apr 20;24(8):7608
5637 cells 0, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM 48 and 72 hours MTX-211 significantly decreased cancer cell viability in a time- and concentration-dependent manner Int J Mol Sci. 2023 Apr 20;24(8):7608
ABCG2-transfected HEK293 cells R482-HEK293 27.94 ± 4.45 µM 72 hours Evaluate the cytotoxicity of MTX-211 on R482-HEK293 cells, IC50 value was 27.94 ± 4.45 µM, showing resistance to MTX-211 Int J Mol Sci. 2024 May 9;25(10):5160
HEK293 cells 1.36 ± 0.16 µM 72 hours Evaluate the cytotoxicity of MTX-211 on HEK293 cells, IC50 value was 1.36 ± 0.16 µM Int J Mol Sci. 2024 May 9;25(10):5160
ABCG2-overexpressing human non-small cell lung cancer (NSCLC) cell line H460-MX20 14.94 ± 2.75 µM 72 hours Evaluate the cytotoxicity of MTX-211 on H460-MX20 cells, IC50 value was 14.94 ± 2.75 µM, showing resistance to MTX-211 Int J Mol Sci. 2024 May 9;25(10):5160
human non-small cell lung cancer (NSCLC) cell line H460 2.97 ± 0.32 µM 72 hours Evaluate the cytotoxicity of MTX-211 on H460 cells, IC50 value was 2.97 ± 0.32 µM Int J Mol Sci. 2024 May 9;25(10):5160
ABCG2-overexpressing human colon cancer cell line S1-MI-80 21.88 ± 2.32 µM 72 hours Evaluate the cytotoxicity of MTX-211 on S1-MI-80 cells, IC50 value was 21.88 ± 2.32 µM, showing resistance to MTX-211 Int J Mol Sci. 2024 May 9;25(10):5160
human colon cancer cell line S1 1.24 ± 0.09 µM 72 hours Evaluate the cytotoxicity of MTX-211 on S1 cells, IC50 value was 1.24 ± 0.09 µM Int J Mol Sci. 2024 May 9;25(10):5160

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Bladder cancer xenograft model 10 mg/kg bodyweight Once every two days, for 21 days MTX-211 significantly inhibited the growth of xenograft tumors Int J Mol Sci. 2023 Apr 20;24(8):7608

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.09mL

0.42mL

0.21mL

10.45mL

2.09mL

1.05mL

20.91mL

4.18mL

2.09mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories